Testing effectiveness (Phase 2)Study completedNCT02317861
What this trial is testing
A PD/Safety Study of RDEA3170 in Combination With Febuxostat for Treating Gout or Asymptomatic Hyperuricemia Patients
Who this might be right for
Gout and Asymptomatic Hyperuricemia
AstraZeneca 110